UZH-founded skin graft creator Cutiss has welcomed series A investors led by Giammaria Giuliani in a bid to provide improved healing of dermatological scars left by reconstructive or plastic surgery.
Cutiss, a Switzerland-based skin graft developer spun out from University of Zurich (UZH), closed a SFr7.3m ($7.2m) series A round today led by private investor Giammaria Giuliani.
State-owned bank Zürcher Kantonalbank took part in the round, as did investment partnership Yellowstone Holding and a number of unnamed private investors.
Founded in 2017, Cutiss is preparing phase 2 clinical studies of a cell-based skin graft technology called DenovoSkin that would be applied to treat scars left from reconstructive and…
